Cytokinetics, Incorporated (CYTK)

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $7.20 billion as of October 7, 2025. Its market cap has increased by 10.06% in one year.

• Market Cap: 7.20B
• Enterprise Value: 7.33B
• 1-Year Change: 10.06%
• Ranking: #1116
• Category: Mid-Cap
• Stock Price: $60.17

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $7.20B, an increase of 1,617.09%. That is a compound annual growth rate of 14.17%.

Market Cap History

Date	Market Cap	% Change
Oct 6, 2025	7.26B	30.71%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%
Apr 30, 2004	419.30M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	753.98B
Johnson & Johnson	454.31B
AbbVie	413.22B
UnitedHealth Group	326.22B
Novo Nordisk	264.73B
AstraZeneca	264.35B
Novartis AG	256.18B
Abbott Laboratories	234.25B